Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 9, 2022
Grant Date -
Jun 3, 2021
app pub date -
Jan 10, 2020
filing date -
Jul 9, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present invention provides compositions and methods based on genetic polymorphisms that are associated with cardiovascular diseases, particularly coronary heart disease (especially myocardial infarction) or hypertension. For example, the present invention relates to nucleic acid molecules containing the polymorphisms, variant proteins encoded by these nucleic acid molecules, reagents for detecting the polymorphic nucleic acid molecules and variant proteins, and methods of using the nucleic acid molecules and proteins as well as methods of using reagents for their detection.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2020 Application Filing Year
- C12Q Class
- 3864 Applications Filed
- 1350 Patents Issued To-Date
- 34.94 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- C12Q Class
- 0 % this patent is cited more than
- 3 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Feb 9, 2026 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Feb 9, 2030 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Feb 9, 2034 |
